Table 4. HPV genotype-specific risks of CIN 2/3/Cancer compared with normal/CIN 1.

Cervical lesion	Genotype	OR	95% CI	p-value
Cervical cancer vs. Normal	HPV 16	17.1	11.6–25.4	<0.001
	HPV 33	3.4	1.5–7.6	0.002
CIN 3 vs. Normal	HPV 16	7.6	5.2–11.3	<0.001
	HPV 31	3.9	2.0–7.5	<0.001
	HPV 33	3.1	1.4–7.1	0.006
CIN 2 vs. Normal	HPV 58	2.0	1.3–3.0	0.001
	HPV 16	1.7	1.1–2.6	0.023
	HPV 52	1.6	1.1–2.1	0.014
Cervical cancer vs. CIN 1	HPV 16	24.8	15.9–38.6	<0.001
	HPV 31	6.2	2.1–18.1	<0.001
	HPV 33	3.0	1.5–6.6	0.005
CIN 3 vs. CIN 1	HPV 16	11.0	7.1–17.1	<0.001
	HPV 31	11.9	4.2–33.5	<0.001
	HPV 33	2.8	1.3–6.0	0.012
CIN 2 vs. CIN 1	HPV 31	5.5	1.9–16.1	0.001
	HPV 16	2.4	1.5–3.9	<0.001